NASDAQ: ORIAOrion Biotech Opportunities Corp Stock
$10.24+0.02 (+0.2%)
Updated Mar 23, 2023
ORIA Price
$10.24
Fair Value Price
N/A
Market Cap
$255.88M
52 Week Low
$9.71
52 Week High
$10.65
P/E
17.35x
P/B
-34.63x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$6.57M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.1
Operating Cash Flow
-$439k
Beta
-0.02
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
ORIA Overview
Orion Biotech Opportunities Corp. is a "blank check" company formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It targets the biotechnology and life sciences sectors. Orion Biotech Opportunities was founded in 2021 and is headquartered in New York, NY.
Zen Score
–
Industry Average (7)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ORIA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ORIA is good value based on its earnings relative to its share price (17.35x), compared to the US market average (21.44x)
P/E vs Market Valuation
ORIA is good value based on its earnings relative to its share price (17.35x), compared to the US Shell Companies industry average (21.14x)
P/E vs Industry Valuation
ORIA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more ORIA due diligence checks available for Premium users.
Be the first to know about important ORIA news, forecast changes, insider trades & much more!
ORIA News
Valuation
ORIA fair value
Fair Value of ORIA stock based on Discounted Cash Flow (DCF)
Price
$10.24
Fair Value
$10.11
Overvalued by
1.32%
ORIA price to earnings (PE)
For valuing profitable companies with steady earnings
Company
17.35x
Industry
21.14x
Market
21.44x
ORIA is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
ORIA is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
ORIA price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-34.63x
Industry
-37.93x
ORIA's financial health
Profit margin
Revenue
$0.0
Net Income
$920.3k
Profit Margin
0%
ORIA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$201.8M
Liabilities
$8.1M
Debt to equity
-1.1
ORIA's short-term assets ($633.22k) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ORIA's long-term liabilities ($8.06M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ORIA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ORIA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$77.5k
Investing
$0.0
Financing
$0.0
ORIA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
ORIA vs Shell Company Stocks
Orion Biotech Opportunities Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.